Disease/Infection News

RSS

Discovery of SARS-CoV-2 neutralizing antibodies from a naïve human Ab library

Now, a new preprint research paper published on the bioRxiv server shows how closely the antibodies formed in exposed humans resemble the germline antibody molecules. This could lead to the development of novel therapeutics to counter the pandemic.

12 Jan 2021

Patient with hypertension or cardiovascular diseases experienced critical disease progression with COVID-19

COVID-19 patients who also suffer from high blood pressure are more likely to fall severely ill with the disease, which also leaves them at greater risk of death.

11 Jan 2021

COVID-19 taking a disproportionate toll on female healthcare workers

Women in the healthcare workforce seem to be suffering stress and burnout in the current pandemic situation, disproportionately when compared to men, suggests a new preprint research paper published on the medRxiv server.

11 Jan 2021

SARS-CoV-2 exposure in England could be double reported seroprevalence

A new study that recently appeared on the preprint server medRxiv* makes use of a combined method to estimate population exposure to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), taking into account the fact that patients who recover from the infection often do not have circulating antibodies against the virus.

11 Jan 2021

The mystery of Giglio island’s resistance to COVID-19

An intriguing new study explores the mechanisms by which an Italian island called Giglio remained resistant to coronavirus disease 2019 (COVID-19) even after much exposure.

11 Jan 2021

Study supports continuing phase 3 trials of Ad26.COV2.S SARS-CoV-2 vaccine

An international team of researchers has provided further evidence to confirm the immunogenicity and efficacy of a recombinant adenovirus vaccine currently being tested in phase 3 trials for its ability to protect against infection with severe acute respiratory coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

11 Jan 2021

Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro

Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

11 Jan 2021

Study aims to halt further isolation of people aging with HIV during COVID-19 pandemic

The School of Medicine at the University of California, Riverside, has received a grant aimed at halting further isolation of people aging with HIV during the COVID-19 pandemic.

11 Jan 2021

Antibody recognition of linear SARS-CoV-2 epitopes preserved in mutated B.1.1.7 strain

In a recent medRxiv research paper, the US scientists examined the effects of non-synonymous mutations in the circulating B.1.1.7 strain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on linear antibody epitope signal for viral spike glycoprotein and nucleoprotein – and demonstrated that mutations should not result in immune evasion.

11 Jan 2021

Infectious disease early warning system compensates for existing gaps in surveillance

Researchers at Columbia University Mailman School of Public Health developed an infectious disease early warning system that includes areas lacking health clinics participating in infectious disease surveillance.

11 Jan 2021

Study finds association between severity of COVID-19 and shorter telomeres

Patients with severe COVID-19 disease have significantly shorter telomeres, according to a study conducted by researchers at the Spanish National Cancer Research Centre in collaboration with the COVID-IFEMA Field Hospital, published in the journal Aging.

11 Jan 2021

Over half of COVID-19 cases are spread by asymptomatic carriers, CDC study finds

In a new study conducted by researchers at the U.S. Centers for Disease Control and Prevention (CDC), over half of SARS-CoV-2 infections are believed to be transmitted asymptomatically.

11 Jan 2021

Vimentin could be a major co-factor that aids SARS-CoV-2 infection

A recent study has found that extracellular vimentin can bind to SARS-CoV-2 spike protein in vitro, and antibodies against vimentin can decrease virus infectivity by up to 80%. This suggests vimentin could aid the virus’s binding to host cells and help in infection.

11 Jan 2021

Could Ivermectin be an effective antiviral against SARS-CoV-2?

A double-blind, randomized, placebo-controlled clinical trial has recently demonstrated that Ivermectin, an anti-parasitic drug, can reduce in-hospital mortality rate of COVID-19 patients.

11 Jan 2021

SARS-CoV-2-induced innate immune responses may vary with disease severity, finds study

Scientists from Germany and China recently conducted a large meta-analysis using transcriptome data of SARS-CoV-2 to evaluate the routes of viral entry and the characteristics of innate immune responses induced by SARS-CoV-2 infection.

11 Jan 2021

How effective are masks in preventing SARS-CoV-2 transmission?

Can face masks protect against SARS-CoV-2 infection? Faruque Ahmad, MD, recently explored the role of face masks in mitigating the coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2.

11 Jan 2021

Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in China

As asymptomatic transmission chains play a role in SARS-CoV-2’s viral spread, a new study by researchers in Wuhan, China, investigated the seroprevalence and asymptomatic carrier status of SARS-CoV-2 in the region.

11 Jan 2021

Researchers reach important milestone in leishmaniasis vaccine development

Researchers have taken an important step forward in developing a controlled human infection model to test leishmaniasis vaccines.

11 Jan 2021

Study suggests link between T. gondii infection and risk of aggressive brain cancer

A new study suggests a link between toxoplasma gondii (T. gondii) infection and the risk of glioma, a type of brain cancer, in adults.

11 Jan 2021

New agent-based model can be used for making informed choices regarding COVID-19 restrictions

What happens when municipalities in the Copenhagen area experience a COVID-19 flare-up? Would closing the schools have any effect, or would a better choice be directing the parents to work from home? Due to the COVID-19 pandemic, authorities worldwide have several times implemented steps to keep the pandemic in check.

11 Jan 2021

Disease/Infection News

Discovery of SARS-CoV-2 neutralizing antibodies from a naïve human Ab library

Patient with hypertension or cardiovascular diseases experienced critical disease progression with COVID-19

COVID-19 taking a disproportionate toll on female healthcare workers

SARS-CoV-2 exposure in England could be double reported seroprevalence

The mystery of Giglio island’s resistance to COVID-19

Study supports continuing phase 3 trials of Ad26.COV2.S SARS-CoV-2 vaccine

Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro

Study aims to halt further isolation of people aging with HIV during COVID-19 pandemic

Antibody recognition of linear SARS-CoV-2 epitopes preserved in mutated B.1.1.7 strain

Infectious disease early warning system compensates for existing gaps in surveillance

Study finds association between severity of COVID-19 and shorter telomeres

Over half of COVID-19 cases are spread by asymptomatic carriers, CDC study finds

Vimentin could be a major co-factor that aids SARS-CoV-2 infection

Could Ivermectin be an effective antiviral against SARS-CoV-2?

SARS-CoV-2-induced innate immune responses may vary with disease severity, finds study

How effective are masks in preventing SARS-CoV-2 transmission?

Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in China

Researchers reach important milestone in leishmaniasis vaccine development

Study suggests link between T. gondii infection and risk of aggressive brain cancer

New agent-based model can be used for making informed choices regarding COVID-19 restrictions

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News